Search for: "PFIZER" Results 2001 - 2020 of 4,635
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2013, 9:00 pm by Nietzer
Pfizer - a massive and multi-year internal investigation turned up a plethora of FCPA violations, yet the company received only a $15MM fine. [read post]
14 Jan 2013, 6:19 am by Mark Zamora
Although he took only generics, Weeks accused Wyeth, which sold Reglan and is now owned by Pfizer as well as two generic drugmakers – Teva Pharmaceuticals and Actavis – of failing to warn of the risk of long-term use.At issue was whether Weeks could press his lawsuit against Pfizer, a question that a federal court asked the Alabama Supreme Court to decide. [read post]
9 Jan 2013, 9:00 pm by Nietzer
In the recent Pfizer Deferred Prosecution Agreement (DPA), it stated regarding the CCO position (called Chief Compliance and Risk Officer) that: Pfizer will: a. [read post]
9 Jan 2013, 4:14 am by David C. Scileppi
  I wanted to thank Bob Lamm, Assistant General Counsel and Assistant Secretary at Pfizer Inc., and Stacey Geer, Senior Vice President and Associate General Counsel at Primerica, Inc., both of whom were especially helpful in coming up with this list. [read post]
8 Jan 2013, 5:57 am
Pfizer and Endo Pharmaceuticals reached a settlement with the State of Texas to pay $50 million to settle a lawsuit accusing these drug companies of falsifying drug prices to bleed Texas' Medicaid program. [read post]
7 Jan 2013, 12:38 am by Kevin LaCroix
None of the 2012 enforcement settlements were sufficient to make The FCPA Blog’s all-time top ten FCPA criminal fines list but Pfizer’s $45.2 million disgorgement did make the blog’s top ten FCPA disgorgements list. [read post]
3 Jan 2013, 2:15 pm by Howard Knopf
PATENT LAWWill Pfizer succeed in its very unusual attempt to get the Supreme Court of Canada (“SCC”) to change its mind following the recent ruling in the Viagra case that rendered its patent “void”- period - and not just invalid as against Teva for Notice of Compliance purposes? [read post]
3 Jan 2013, 12:28 am by Kevin LaCroix
The year just finished included dramatic and important developments involving elections, tragedies and natural disasters. [read post]
31 Dec 2012, 11:41 pm by Shouvik Kumar Guha
Next in line is a guest post by Madhulika Vishwanathan in the Spicy IP Fellowship Post Series, wherein she has referred to few landmark judgments in 2012 pertaining to the Indian pharmaceutical patent industry, including the grant of compulsory license to Natco Pharma, revocation of the Sunitinib patent owned by Pfizer/Sugen, the Roche-Cipla patent infringement suit, revocation of India’s first pharmaceutical product patent etc. [read post]
31 Dec 2012, 1:52 pm by Swaraj Paul Barooah
Sunitinib, patented by Pfizer/Sugen, a drug used to treat abnormal protein kinase activity was revoked by Indian patent office in a post grant opposition by Cipla on the grounds of obviousness. [read post]
20 Dec 2012, 12:35 am by Kevin LaCroix
Swiss banking giant UBS has become the second global financial institution to enter a series of massive regulatory settlements in connection with the ongoing Libor scandal investigation. [read post]
11 Dec 2012, 10:52 pm
Zoloft is a Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant manufactured by Pfizer. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
For insured patients, the copayment is typically $25 to $50, well above the average copayment of about $10 a month for a generic drug.Under Pfizer’s Lipitor For You coupon program, Pfizer absorbs up to $75 of the patient’s out-of-pocket cost. [read post]
1 Dec 2012, 8:00 pm by Lawrence B. Ebert
For insured patients, the copayment is typically $25 to $50, well above the average copayment of about $10 a month for a generic drug.Under Pfizer’s Lipitor For You coupon program, Pfizer absorbs up to $75 of the patient’s out-of-pocket cost. [read post]
29 Nov 2012, 1:59 pm by Amber Walsh
Pfizer Inc. has acquired NextWave Pharmaceuticals Inc. for $782 million in cash. [read post]